
|Articles|March 1, 1996
Supplements and Featured Publications
- Current Strategies in the Treatment of Cardiovascular Diseases: The Role of Beta-Blocker Therapy
- Volume 2
- Issue 5 Suppl
Sympathetic Modulation in Congestive Heart Failure: Where Do Beta-Blockers Stand?
Author(s)Finn Waagstein, MD, PhD
Advertisement
Articles in this issue
almost 30 years ago
Introductionalmost 30 years ago
Utilization of Beta-Blockers: A First-Line Therapy in Hypertensionalmost 30 years ago
Suggested Readingalmost 30 years ago
ParticipantsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
2
52-Week VERIFY Data Show Rusfertide Brings Sustained Responses in PV
3
Once-Monthly Maridebart Cafraglutide Shows Up to 16% Weight Loss
4
New TROP2-Targeted ADC Shows Promise in TNBC: Erika Hamilton, MD
5














































